Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
Aspen Investment Management Inc Has $895,000 Holdings in AbbVie Inc. $ABBV
04:34am, Wednesday, 19'th Nov 2025
Aspen Investment Management Inc grew its position in AbbVie Inc. (NYSE: ABBV) by 6.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exch
AbbVie Inc. $ABBV Shares Bought by ARS Investment Partners LLC
03:56am, Wednesday, 19'th Nov 2025
ARS Investment Partners LLC increased its position in AbbVie Inc. (NYSE: ABBV) by 1.3% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exc
AbbVie Inc. $ABBV Stock Position Lowered by Alteri Wealth LLC
03:09am, Wednesday, 19'th Nov 2025
Alteri Wealth LLC trimmed its position in shares of AbbVie Inc. (NYSE: ABBV) by 21.7% during the undefined quarter, according to the company in its most recent filing with the SEC. The institutional i
- EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is now the first and only bispecific antibody combination therapy available for patients with relapsed or refractory follicular lymphoma
Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3
10:41am, Tuesday, 18'th Nov 2025
ABBV's neuroscience drugs drive strong Q3 momentum, with rising Botox Therapeutic sales, migraine therapies and new PD treatments fueling growth.
It's Best Time In 10 Years To Lock In Income: Our Picks
09:00am, Tuesday, 18'th Nov 2025
Investors can now access 4–7% from top-quality REITs, 3.5%+ from dividend ETFs, and 6%+ from midstream infrastructure — without taking on excessive risk. While the S&P 500 is up ~110% since 2020,
AbbVie Stock Falls 4% -- What Investors Need to Know
07:17am, Monday, 17'th Nov 2025
It's no reason to stay up at night.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
07:25am, Saturday, 15'th Nov 2025
AbbVie is a Dividend King with a bright future. Enbridge offers an especially dependable dividend.
AbbVie Inc. (ABBV) Presents at 7th Annual Healthcare Symposium Transcript
04:31pm, Friday, 14'th Nov 2025
AbbVie Inc. ( ABBV ) 7th Annual Healthcare Symposium November 14, 2025 11:55 AM EST Company Participants Michael Paas Conference Call Participants Elena Meng Michelle Kehily Stephen Morse Magdalena So
Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman
03:19pm, Friday, 14'th Nov 2025
Evan Seigerman, BMO Capital Markets head of health care research, joins 'Power Lunch' to discuss what's behind the recent move in health care stocks, the state of play with GLP-1s and much more.
Arvest Bank Trust Division Sells 323 Shares of AbbVie Inc. $ABBV
04:12am, Friday, 14'th Nov 2025
Arvest Bank Trust Division decreased its stake in shares of AbbVie Inc. (NYSE: ABBV) by 0.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commis
Robert Bruce's Strategic Moves: AT&T Inc. Sees a -1.41% Portfolio Impact
04:02pm, Thursday, 13'th Nov 2025
Insightful Analysis of Robert Bruce (Trades, Portfolio)'s Third Quarter 2025 13F Filing Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for
AbbVie Announces 20 Recipients of Migraine Career Catalyst Award™
08:30am, Thursday, 13'th Nov 2025
As a leader in migraine treatment, AbbVie is committed to addressing the impact of migraine in the workplace. 2025 honorees represent a diverse group of achievers—from teachers and authors to small
Here Are Thursday's Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More
08:10am, Thursday, 13'th Nov 2025
The stock futures are trading lower on Thursday, following another incredible day for the Dow Jones Industrials, while the rotation out of the NASDAQ and into technology is still gaining traction.
2 Strong Healthcare Stock Picks for Dividend Investors
03:55am, Thursday, 13'th Nov 2025
These companies have exceptional dividend track records. AbbVie is moving on from its Humira patent losses, and its portfolio benefits from some exceptionally profitable products.
